The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy | Official website vaccine against COVID-19 Sputnik V.

Generating your feed, please be patient ...

Latest news

The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy | Official website vaccine against COVID-19 Sputnik V. | Zootzle

Trending today

Latest news